RT Conference Proceedings
T1 Ustekinumab is an effective and safe therapy in anti-TNF refractory Crohn's Disease: a two year real-life observational study from Spain
A1 Rueda Sanchez, J.
A1 Cabello Ramirez, N.
A1 Camara Baena, S.
A1 Keco Huerga, A.
A1 de la Borbolla Serres, J. Garcia
A1 Castro Fernandez, M.
A1 Grande Santamaria, L.
PB Oxford univ press
SN 1873-9946
YR 2021
FD 2021-05-01
LK https://hdl.handle.net/10668/27120
UL https://hdl.handle.net/10668/27120
LA en
DS RISalud
RD Apr 9, 2025